Geneos Wealth Management Inc. Roivant Sciences Ltd. Transaction History
Geneos Wealth Management Inc.
- $2.77 Billion
- Q4 2024
A detailed history of Geneos Wealth Management Inc. transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Geneos Wealth Management Inc. holds 100 shares of ROIV stock, worth $1,044. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100
Previous 100
-0.0%
Holding current value
$1,044
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ROIV
# of Institutions
330Shares Held
511MCall Options Held
1.14MPut Options Held
1.26M-
Sb Investment Advisers (Uk) LTD London, X065.9MShares$688 Million6.27% of portfolio
-
Qvt Financial LP New York, NY65.8MShares$687 Million73.2% of portfolio
-
Viking Global Investors LP54.1MShares$565 Million2.42% of portfolio
-
Vanguard Group Inc Valley Forge, PA44.1MShares$460 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$369 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.35B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...